Angelica Anamaria Hanc is a Investor Relations Partner at Innovation Platform Capital, where she supports investor relations, platform communications, and the development of investment materials across the firm’s global portfolios.

She brings experience across healthcare, investment analysis, and operational support, having contributed to process optimisation initiatives at Vitema Pharmaceuticals and financial modelling and investment support activities at KgC Montgomery.

Her work focuses on translating complex investment strategies into clear, structured communication for investors and stakeholders, supporting capital formation and engagement across iPC’s platform.

Angelica holds a Master’s degree in Neurobiology and Behaviour from Babeș-Bolyai University and has completed studies in private equity and investment management.